ArticleTranslational lung cancer research2025
The effects of neoadjuvant sintilimab versus pembrolizumab combined with chemotherapy on resectable non-small cell lung cancer: a multicenter propensity score-matched study.
Yichen Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.